Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 119, Issue 2, 2001, Pages 350-357

  Sharief, M K ^a   Semra, Y K ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Cerebrospinal fluid; Inhibitors of apoptosis proteins; Multiple sclerosis

Indexed keywords

FAS ANTIGEN; INHIBITOR OF APOPTOSIS PROTEIN; MITOGENIC AGENT; PROTEIN BCL 2; PROTEIN IAP 1; PROTEIN IAP 2; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CELL STIMULATION; CELL VIABILITY; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD95; APOPTOSIS; CEREBROSPINAL FLUID; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LYMPHOCYTE ACTIVATION; MITOGENS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 0035479010     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00365-4     Document Type: Article

References (37)

1. Biochemical pathways of caspase activation during apoptosis
2. Apoptotic and effector pathways in autoimmunity
3. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients
4. Defective T cell Fas function in patients with multiple sclerosis
5. Resistance to glucocorticoid-induced apoptosis in PLP peptide-specific T cell clones from patients with progressive MS
6. Lipopolysaccharide induces the expression of cellular inhibitor of apoptosis protein-2 in human macrophages
7. IAP family proteins: Suppressors of apoptosis
8. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
9. Endogenous inhibitors of caspases
10. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy
11. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation
12. CD95's deadly mission in the immune system
13. KIAP, a novel member of the inhibitor of apoptosis protein family
14. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis
15. Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine
16. An exegesis of IAPs: Salvation and surprises from BIR motifs
17. The Bcl-2 family and cell death regulation
18. Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance
19. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
20. Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy
21. Apoptosis signaling in lymphocytes
22. T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy
23. Fas(t) track to apoptosis in MS-TNF receptors may suppress or potentiate CNS demyelination
24. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis
25. Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis
26. Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple sclerosis
27. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells
28. Inhibition of Fas death signals by FLIPs
29. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes
30. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
31. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
32. The IAP family: Endogenous caspase inhibitors with multiple biological activities
33. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
34. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis
35. Bcl-2 expressing T lymphocytes in multiple sclerosis lesions
36. Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis
37. Immune (dys)regulation in multiple sclerosis: Role of the CD95-CD95 ligand system